Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation

Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation

Homologous recombination deficiency (HRD) is characterized by the inability of a cell to repair the double-stranded breaks using the homologous recombination repair (HRR) pathway. The deficiency of the HRR pathway results in defective DNA repair, leading to genomic instability and tumorigenesis. The...

Full description

Bibliographic Details
Main Authors:	Nikhil Shri Sahajpal, Ashis K. Mondal, Ashutosh Vashisht, Harmanpreet Singh, Andy Wing Chun Pang, Daniel Saul, Omar Nivin, Benjamin Hilton, Barbara R. DuPont, Vamsi Kota, Natasha M. Savage, Alex R. Hastie, Alka Chaubey, Ravindra Kolhe
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Genes
Subjects:	optical genome mapping homologous recombination deficiency HRD scores
Online Access:	https://www.mdpi.com/2073-4425/14/9/1683

Similar Items

Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers
by: Nikhil Shri Sahajpal, et al.
Published: (2023-06-01)

Homologous Recombination Deficiency Detection Algorithms: A Systematic Review
by: Lasse Ringsted Mark, et al.
Published: (2023-11-01)

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
by: Xin Wu, et al.
Published: (2022-11-01)

Biomarkers for Homologous Recombination Deficiency in Cancer
by: Svenja Wagener-Ryczek, et al.
Published: (2021-06-01)

Immune Factors Drive Expression of SARS-CoV-2 Receptor Genes Amid Sexual Disparity
by: Ashutosh Vashisht, et al.
Published: (2023-02-01)

Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses
by: Nikhil Shri Sahajpal, et al.
Published: (2021-03-01)

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
by: Vilma Pacheco-Barcia, et al.
Published: (2022-06-01)

PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials
by: István Baradács, et al.
Published: (2024-02-01)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
by: Sha Zhu, et al.
Published: (2022-07-01)

P549: Analysis of challenging products of conception cases with optical genome mapping: A preliminary study
by: Nikhil Sahajpal, et al.
Published: (2023-01-01)

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
by: Wang Daodu, et al.
Published: (2022-05-01)

Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy
by: Umer Ali, et al.
Published: (2024-01-01)

How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature
by: Martina Arcieri, et al.
Published: (2024-03-01)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
by: Jan Budczies, et al.
Published: (2022-07-01)

Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)
by: Michael Menzel, et al.
Published: (2023-09-01)

Homologous Recombination Deficiencies and Hereditary Tumors
by: Hideki Yamamoto, et al.
Published: (2021-12-01)

Human Resource Development Climate in Banks
by: Dr.Sasmita Nayak
Published: (2016-06-01)

Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer
by: Morgan Bailey, et al.
Published: (2024-03-01)

Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations
by: Stanislas Quesada, et al.
Published: (2022-02-01)

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
by: Lara Planas‐Paz, et al.
Published: (2023-04-01)

Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
by: Alessandro Mangogna, et al.
Published: (2023-02-01)

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
by: Gaoming Liao, et al.
Published: (2022-02-01)

Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
by: Eva-Maria Willing, et al.
Published: (2023-06-01)

Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology
by: Goldin John, et al.
Published: (2021-07-01)

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma
by: Xueqian Shang, et al.
Published: (2022-09-01)

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
by: Takayuki Ueno, et al.
Published: (2022-04-01)

Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay
by: Giovanni L. Scaglione, et al.
Published: (2023-12-01)

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
by: Alexander Scheiter, et al.
Published: (2022-08-01)

A course in homological algebra /
by: 198017 Hilton, Peter John, et al.
Published: (1997)

A course in homological algebra /
by: 198017 Hilton, Peter John, et al.
Published: (1971)

Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
by: Cyril Roussel-Simonin, et al.
Published: (2023-11-01)

BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib
by: Carolina Velazquez, et al.
Published: (2023-03-01)

Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment
by: Pankaj Ahluwalia, et al.
Published: (2021-08-01)

Evaluation of the Effectiveness of Active HRD Systems for Dust Explosion Suppression in a Technology Demonstrator System
by: Piotr Lesiak, et al.
Published: (2019-06-01)

Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine
by: Pankaj Ahluwalia, et al.
Published: (2024-01-01)

Optical Genome Mapping and Single Nucleotide Polymorphism Microarray: An Integrated Approach for Investigating Products of Conception
by: Nikhil Shri Sahajpal, et al.
Published: (2022-04-01)

Homologous Recombination Deficiency Associated With Response to Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer Patients: The First Real-World Evidence From China
by: Jing Ni, et al.
Published: (2022-01-01)

Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer
by: Seung Jin Kim, et al.
Published: (2021-02-01)

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
by: Marjolijn M. Ladan, et al.
Published: (2021-02-01)

Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer
by: Svetlana Magadeeva, et al.
Published: (2023-12-01)